Clinical Trial Update: PROMUS PREMIER™ China Post-Approval Study

View source ↗

Summary

Post-approval study update for the PROMUS PREMIER coronary stent in China, reporting completion status for patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PROMUS PREMIER

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Status: COMPLETED